Faje, A. T., Lawrence, D., Flaherty, K., Freedman, C., Fadden, R., Rubin, K., . . . Sullivan, R. J. (2018). High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer, 124(18), 3706-3714. https://doi.org/10.1002/cncr.31629
Chicago Style (17th ed.) CitationFaje, Alexander T., Donald Lawrence, Keith Flaherty, Christine Freedman, Riley Fadden, Krista Rubin, Justine Cohen, and Ryan J. Sullivan. "High‐dose Glucocorticoids for the Treatment of Ipilimumab‐induced Hypophysitis Is Associated with Reduced Survival in Patients with Melanoma." Cancer 124, no. 18 (2018): 3706-3714. https://doi.org/10.1002/cncr.31629.
MLA (9th ed.) CitationFaje, Alexander T., et al. "High‐dose Glucocorticoids for the Treatment of Ipilimumab‐induced Hypophysitis Is Associated with Reduced Survival in Patients with Melanoma." Cancer, vol. 124, no. 18, 2018, pp. 3706-3714, https://doi.org/10.1002/cncr.31629.